INTRA-CELLULAR THERAPIES INC

CUSIP: 46116X101 Class: Common Stock

Ensign Peak Advisors, Inc's Holding History (CIK: 0001454984)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024
Shares 29,562 Value ($000) $2,469 Avg Close — Range —
Q3 2024
Shares 28,264 Value ($000) $2,068 Avg Close — Range —
Q2 2024
Shares 41,637 Value ($000) $2,852 Avg Close — Range —
Q1 2024
Shares 141,637 Value ($000) $9,801 Avg Close — Range —
Q4 2023
Shares 43,063 Value ($000) $3,084 Avg Close — Range —
Q3 2023
Shares 43,063 Value ($000) $2,243 Avg Close — Range —
Q2 2023
Shares 43,888 Value ($000) $2,779 Avg Close — Range —
Q1 2023
Shares 43,888 Value ($000) $2,377 Avg Close — Range —
Q4 2022
Shares 26,940 Value ($000) $1,426 Avg Close — Range —
Q3 2022
Shares 24,340 Value ($000) $1,133 Avg Close — Range —
Q2 2022
Shares 125,493 Value ($000) $7,164 Avg Close — Range —
Q1 2022
Shares 134,553 Value ($000) $8,233 Avg Close — Range —
Q4 2021
Shares 123,327 Value ($000) $6,455 Avg Close — Range —
Q3 2021
Shares 84,260 Value ($000) $3,142 Avg Close — Range —
Q2 2021
Shares 71,797 Value ($000) $2,931 Avg Close — Range —
Q1 2021
Shares 71,797 Value ($000) $2,436 Avg Close — Range —
Q4 2020
Shares 71,797 Value ($000) $2,283 Avg Close — Range —
Q3 2020
Shares 27,991 Value ($000) $718 Avg Close — Range —